Guardant Health, Inc. (BMV:GH)
Mexico · Delayed Price · Currency is MXN 820.00
-23.00 (-2.73%)
At close: May 12, 2025
Intra-Cellular Therapies Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2020 |
Net Income | -413.82 | -436.37 | -479.45 | -654.59 | -405.67 | -253.78 | Upgrade |
Depreciation & Amortization | 41.33 | 42.39 | 42.88 | 35.96 | 22.27 | 16.07 | Upgrade |
Other Amortization | 2.58 | 2.58 | 2.58 | 2.57 | 2.56 | 4.73 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | - | - | 8.5 | Upgrade |
Loss (Gain) From Sale of Investments | -2.91 | 37.63 | -64.21 | 17.65 | 12.85 | 4.02 | Upgrade |
Stock-Based Compensation | 166.35 | 140.41 | 90.76 | 94.69 | 151.45 | 144.11 | Upgrade |
Other Operating Activities | 26.53 | 34.37 | 28.63 | 132.7 | 47.99 | 12.95 | Upgrade |
Change in Accounts Receivable | -30.08 | -21.39 | 8.38 | 0.38 | -44.35 | -5.46 | Upgrade |
Change in Inventory | -17.08 | -9.14 | -10.35 | -20.93 | -7.96 | -7.54 | Upgrade |
Change in Accounts Payable | 7.93 | -2.82 | 5.19 | 60.33 | 34.8 | 0.51 | Upgrade |
Change in Unearned Revenue | 25.32 | 18.66 | 1.73 | 9.87 | 2.78 | -3.73 | Upgrade |
Change in Other Net Operating Assets | -44.71 | -46.18 | 48.89 | 11.91 | -25.73 | -31.45 | Upgrade |
Operating Cash Flow | -238.55 | -239.86 | -324.98 | -309.46 | -209.02 | -103.93 | Upgrade |
Capital Expenditures | -33.18 | -35.09 | -20.49 | -77.46 | -75.04 | -36.17 | Upgrade |
Sale (Purchase) of Intangibles | - | - | - | - | - | -17.89 | Upgrade |
Investment in Securities | 41.1 | -226.22 | 860.74 | 227.28 | 11.88 | -563.03 | Upgrade |
Investing Cash Flow | 7.92 | -261.31 | 840.25 | 149.82 | -63.16 | -617.09 | Upgrade |
Long-Term Debt Issued | - | - | - | - | - | 1,133 | Upgrade |
Long-Term Debt Repaid | - | - | - | - | - | -0.17 | Upgrade |
Net Debt Issued (Repaid) | - | - | - | - | - | 1,133 | Upgrade |
Issuance of Common Stock | 15.05 | 14.84 | 503.68 | 11.94 | 17.87 | 372.35 | Upgrade |
Repurchase of Common Stock | -78.83 | -15.68 | -11.2 | -7.88 | -83.76 | -3.45 | Upgrade |
Other Financing Activities | -7.28 | -0.15 | -15.1 | -193.16 | -0.93 | -91.18 | Upgrade |
Financing Cash Flow | -71.05 | -1 | 477.38 | -189.09 | -66.82 | 1,410 | Upgrade |
Foreign Exchange Rate Adjustments | 1.92 | -1.77 | -0.91 | -1.6 | -1.69 | 0.46 | Upgrade |
Net Cash Flow | -299.76 | -503.93 | 991.74 | -350.34 | -340.69 | 689.75 | Upgrade |
Free Cash Flow | -271.73 | -274.94 | -345.46 | -386.92 | -284.05 | -140.1 | Upgrade |
Free Cash Flow Margin | -32.78% | -37.20% | -61.26% | -86.07% | -76.02% | -48.86% | Upgrade |
Free Cash Flow Per Share | -2.20 | -2.24 | -3.08 | -3.79 | -2.80 | -1.44 | Upgrade |
Cash Income Tax Paid | 1.01 | 1.01 | 1.97 | 1.33 | 0.39 | 0.33 | Upgrade |
Levered Free Cash Flow | -131.17 | -146.83 | -178.19 | -295.57 | -123.48 | -75.82 | Upgrade |
Unlevered Free Cash Flow | -131.84 | -147.79 | -179.16 | -296.52 | -124.43 | -77.57 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.